NovaBay Pharmaceuticals CEO Justin Hall's 2020 pay jumps 129% to $747K
NovaBay Pharmaceuticals reports 2020 executive compensation
By ExecPay News
Published: April 7, 2021
NovaBay Pharmaceuticals reported fiscal year 2020 executive compensation information on April 7, 2021.
In 2020, four executives at NovaBay Pharmaceuticals received on average a compensation package of $466K, a 108% increase compared to previous year.
Average pay of disclosed executives at NovaBay Pharmaceuticals
Justin M. Hall, Chief Executive Officer, received $747K in total, which increased by 129% compared to 2019. 46% of Hall's compensation, or $347K, was in option awards. Hall also received $114K in bonus, $286K in salary, as well as $720 in other compensation.
Andrew Jones, Chief Financial Officer, received a compensation package of $737K. 45% of the compensation package, or $334K, was in option awards.
Wang Xu, Senior Manager and Controller, earned $299K in 2020, a 78% increase compared to previous year.
Jason Raleigh, Chief Financial Officer, received $83K in 2020, which decreases by 75% compared to 2019.
Related executives
You may also like
Source: SEC filing on April 7, 2021.